Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.52M Buy
106,210
+3,401
+3% +$208K 0.46% 55
2026
Q1
$7.14M Buy
102,809
+7,688
+8% +$592K 0.57% 51
2025
Q4
$7.24M Buy
95,121
+397
+0.4% +$31.9K 0.55% 52
2025
Q3
$8.17M Buy
94,724
+2,605
+3% +$196K 0.6% 51
2025
Q2
$6.28M Sell
92,119
-7,431
-7% -$460K 0.49% 55
2025
Q1
$5.92M Buy
+99,550
New +$6.31M 0.5% 54

Other funds holding APTV

Nixon Peabody Trust's APTV Position: Q2 2026 in Review

Nixon Peabody Trust increased its Aptiv (APTV) stake by 3.3% in Q2 2026, buying an estimated $208K and bringing the position to 106,210 shares worth $6.52M. The position accounts for 0.46% of the portfolio, ranked #55.

Nixon Peabody Trust first reported a position in APTV in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.17M in Q3 2025. 168 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • Nixon Peabody Trust held 106,210 shares of Aptiv worth $6.52M as of Q2 2026.
  • Nixon Peabody Trust bought 3,401 Aptiv shares in Q2 2026, an estimated $208K.
  • Aptiv made up 0.46% of Nixon Peabody Trust's portfolio in Q2 2026, its #55 holding.
  • Nixon Peabody Trust first reported a position in Aptiv in Q1 2025 and has held it in 6 quarters since.
  • Nixon Peabody Trust's Aptiv position peaked at $8.17M in Q3 2025.
  • 168 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.